Chinese cancer drug developer Innovent Biologics, which has a number of PE backers, closed up on its Hong Kong trading debut, following a HK$3.3 billion ($421 million) IPO.
The company sold 215 million shares at HK$13.98 apiece, close to the top end of the indicative range. The stock closed up 18.6% on October 31 at HK$16.58. The offering was slightly oversubscribed,...
China’s MSA Capital has joined a $30.5 million round for Saudi Arabian B2B services marketplace Sary as part of a deepening Asia-Middle East agenda.
Huoban.com, a Chinese zero-code application building platform has raised $17 million in Series B funding led by 5Y Capital and Sequoia Capital China. Challenjers Capital also took part in the round.
Apollo Management has submitted a A$4 billion ($3.1 billion) bid for the wagering and media and gaming services businesses of Tabcorp Holdings, Australia’s largest gambling company.
David Swensen, head of the Yale University endowment who pioneered a new approach to institutional investment management, has died aged 67 following a long battle with cancer.